TRAMADOLÃÂ®.......Beyond its Beneficial Effects
Department of Medical and Surgical Emergencies, University Hospital Center Mustapha (Pr.M.Guerinik), Algiers, Algeria
- *Corresponding Author:
- Amine Salmi
Department of Medical and Surgical Emergencies
University Hospital Center Mustapha (Pr.M.Guerinik), Algiers, Algeria
E-mail: [email protected]
Received Date: December 28, 2015 Accepted Date: February 06, 2016 Published Date: February 15, 2016
Citation: Salmi A (2016) TRAMADOL®.......Beyond its Beneficial Effects. J Clin Toxicol 6:282. doi: 10.4172/2161-0495.1000282
Copyright: © 2016 Salmi A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Tramadol® (analgesic of the landing 2) is a centrally acting analgesic with a dual mode of action. Its analgesic efficacy is attributed to its partial affinity for the (μ) mu-opiate receptor and its inhibition of noradrenaline and serotonin reuptake. Acting in a synergistic manner and being more efficacious, Tramadol® is used worldwide for the treatment of moderate to severe acute or chronic pain. If psychotropics are not an exceptional one because of SIADH (syndrome Inappropriate secretion of antidiuretic hormone), analgesics are not usually. This is the case of Tramadol®. We report on this observation the case of a 22 year old patient hospitalized for poisoning Tramadol®, having presented, hyponatremia, hypoglycemia, rhabdomyolyse and left cardiac decompensation.